Benefit from earlier thrombolytic therapy is certain, but what is the magnitude of benefit?
Leizorovicz
A
A
Service de Pharmacologie Clinique, Lyon, France.
D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D015912:Thrombolytic Therapy / Q000379:methods*; D016896:Treatment Outcome